Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant
Clinical trial NCT03212313 · TERMINATED
Trial details
- NCT number
- NCT03212313
- Sponsor
- Biotie Therapies Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2017-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.